drugset / Trial / NCT06284434

Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

NCT06284434

RandomizedParallel-groupTriple-blindSupportive care

Summary

The goal of this clinical trial is to learn if a pain medication called liposomal bupivacaine (brand name EXPAREL®) with epinephrine will provide better pain control, increased activity, and reduced use of opioids compared with the standard treatment for patients age 6 years and older with cleft lip and palate who have had an alveolar bone graft surgery. Investigators will look at: * pain scores at hip and jaw sites * opioid use in amount and frequency * scores on activity questionnaires Researchers will compare the results of these items with those of patients who had the standard treatment of bupivacaine with epinephrine.

Timeline

Start
2024-04-24
Primary completion
2026-04-24
Completion
2026-04-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified Other
Comparator Bupivacaine Other / unclassified
Background Epinephrine Other / unclassified

Indications